Vir Biotechnology Inc (NASDAQ:VIR) Has Recovered -65.03% To Date, But An Additional -192.97% Is Possible.
In last trading session, Vir Biotechnology Inc (NASDAQ:VIR) saw 0.61 million shares changing hands with its beta currently measuring 0.48. Company’s recent per share price